Friday, September 5, 2025
  • Hype
  • Murai
  • Lipstiq
  • Miss Murai
  • Varnam
  • Moviedash
  • Autofreaks
Lowyat.NET
  • News
    • Lifestyle
    • Computing
    • Hardware
    • Internet
    • Rumours & Leaks
    • Software
  • Forums
    • Kopitiam
    • Tradezone
    • Property Talk
    • Finance & Business
    • Fast and Furious
  • Gaming
    • PC Gaming
    • Console
    • Esports
  • Mobile
    • Apps
    • OS
    • Tablets
    • Phones
    • Telco
      • Celcom
      • DiGi
      • Maxis
      • Tune Talk
      • U Mobile
      • Buzzme
  • Pricelists
    • Compu-zoneUpdated
    • ViewnetUpdated
    • Sri ComputersUpdated
    • StartecUpdated
  • More
    • Automotive Tech
    • Drone
    • Enterprise
    • Entertainment
    • Fashion
    • E-Hailing
    • Wearables
No Result
View All Result
Lowyat.NET
  • News
    • Lifestyle
    • Computing
    • Hardware
    • Internet
    • Rumours & Leaks
    • Software
  • Forums
    • Kopitiam
    • Tradezone
    • Property Talk
    • Finance & Business
    • Fast and Furious
  • Gaming
    • PC Gaming
    • Console
    • Esports
  • Mobile
    • Apps
    • OS
    • Tablets
    • Phones
    • Telco
      • Celcom
      • DiGi
      • Maxis
      • Tune Talk
      • U Mobile
      • Buzzme
  • Pricelists
    • Compu-zoneUpdated
    • ViewnetUpdated
    • Sri ComputersUpdated
    • StartecUpdated
  • More
    • Automotive Tech
    • Drone
    • Enterprise
    • Entertainment
    • Fashion
    • E-Hailing
    • Wearables
No Result
View All Result
Lowyat.NET
No Result
View All Result
Home Coronavirus

Paxlovid To Be Made Available At Private Hospitals Soon

Evusheld to also be administered at government hospitals.

by Ian Chee
June 9, 2022
pfizer paxlovid covid-19 treatment drug

[Photo: REUTERS/Jennifer Lorenzini]

80
SHARES
Share on FacebookShare on Twitter

Last month, Health Minister Khairy Jamaluddin said that as of 9 May, the Paxlovid antiviral drug has helped 179 COVID-19 patients fully recover. No side effects were recorded by the patients either. Following this success, the minister says that the drug will soon be made available at private hospitals.

According to FMT, the minister also said that as of 5 June, he number of COVID-19 patients that have recovered following the Paxlovid treatment has gone up to 1364. As before, no side effects were detected among said patients. And given the antiviral drug’s effectiveness in reducing the effects of infection, and by extension the mortality rate, the Ministry of Health is expanding the availability of the drug to patients in private hospitals.

He also adds that the prescription of the Paxlovid antiviral drug is free even in said hospitals. That being said, the usual consultation fees and other charges still apply.

astrazeneca evusheld covid-19
[Photo: Peter Bostrom/AstraZeneca]
On a related note, the health minister also says that the ministry will start administering Evusheld soon. It will be provided in government hospitals as pre-exposure prophylaxis (PrEP) for individuals who are not yet infected, but face high risks of infection.

Unlike the Pfizer-made antiviral drug Paxlovid which is meant to treat COVID-19 infections, the Evusheld drug made by AstraZeneca is meant to prevent infection. Specifically, it’s made for vaccinated but immunocompromised individuals, as well as those who cannot take the vaccine in the first place. Said individuals must also be 12 years of age or older, weighing 40kg or more. Though the drug has to be administered at least two weeks after vaccination, be it after being partially or fully vaccinated.

Evusheld is capable of providing protection to recipients for up to six months after inoculation. This includes the Omicron sub-variants of the virus. Prescription is done via two different drugs, Txagevimab and Cilgavimab, which are to be administered consecutively.

(Source: FMT)

Filed Under astrazenecaCOVID-19drigevusheldpaxlovidpfizertreatment
Updated 4:22 pm, Thu, 9 June 22
http://lowy.at/PFrzh
Share32Tweet20SendShare

Follow us on Instagram, Facebook, Twitter or Telegram for more updates and breaking news. 

No Result
View All Result

TRENDING THIS WEEK

  1. 1
    Transportation

    East Klang Valley Expressway (EKVE) Opens; Toll-Free Travel Until 29 September 2025

  2. 2
    News

    Xiaomi Recalls 33W Power Bank 20,000mAh In Malaysia

  3. 3
    Hardware

    Microsoft Says SSD Failures Not Linked To Windows Updates

  4. 4
    Mobile Phones

    Sony Explains Manufacturing Issues Of The Xperia 1 VII

  5. 5
    Automotive

    QJMotor E-LRT Electric Scooter Lands In Malaysia At RM6,999

NETWORK

  • Hype
  • Murai
  • Lipstiq
  • Miss Murai
  • Varnam
  • Moviedash
  • Autofreaks

ABOUT

  • Advertise
  • Careers
  • Privacy Statement
  • Contact Us
  • Editorial Policy
  • Terms & Conditions

©2025 VIJANDREN RAMADASS. ALL RIGHTS RESERVED.

No Result
View All Result
  • News
    • Lifestyle
    • Computing
    • Hardware
    • Internet
    • Rumours & Leaks
    • Software
  • Forums
    • Kopitiam
    • Tradezone
    • Property Talk
    • Finance & Business
    • Fast and Furious
  • Gaming
    • PC Gaming
    • Console
    • Esports
  • Mobile
    • Apps
    • OS
    • Tablets
    • Phones
    • Telco
      • Celcom
      • DiGi
      • Maxis
      • Tune Talk
      • U Mobile
      • Buzzme
  • Pricelists
    • Compu-zone
    • Viewnet
    • Sri Computers
    • Startec
  • More
    • Automotive Tech
    • Drone
    • Enterprise
    • Entertainment
    • Fashion
    • E-Hailing
    • Wearables

©2025 VIJANDREN RAMADASS. ALL RIGHTS RESERVED.

No Result
View All Result
  • News
    • Lifestyle
    • Computing
    • Hardware
    • Internet
    • Rumours & Leaks
    • Software
  • Forums
    • Kopitiam
    • Tradezone
    • Property Talk
    • Finance & Business
    • Fast and Furious
  • Gaming
    • PC Gaming
    • Console
    • Esports
  • Mobile
    • Apps
    • OS
    • Tablets
    • Phones
    • Telco
      • Celcom
      • DiGi
      • Maxis
      • Tune Talk
      • U Mobile
      • Buzzme
  • Pricelists
    • Compu-zone
    • Viewnet
    • Sri Computers
    • Startec
  • More
    • Automotive Tech
    • Drone
    • Enterprise
    • Entertainment
    • Fashion
    • E-Hailing
    • Wearables

©2025 VIJANDREN RAMADASS. ALL RIGHTS RESERVED.